Interferon-γ:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue

被引:0
作者
Scola, MP
Thompson, SD
Brunner, HI
Tsoras, MK
Witte, D
van Dijk, MA
Grom, AA
Passo, MH
Glass, DN
机构
[1] Childrens Hosp, Med Ctr, William S Rowe Div Rheumatol, Dept Pediat, Cincinnati, OH 45229 USA
[2] Univ Utrecht, Med Ctr, Lab Immunotherapy, Utrecht, Netherlands
[3] Childrens Hosp, Med Ctr, Dept Pathol, Cincinnati, OH 45229 USA
关键词
juvenile rheumatoid arthritis; interleukin; 18; interferon-gamma; 15; synovial tissue; 12;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To compare synovial tissue cytokine mRNA expression between patients with juvenile rheumatoid arthritis (JRA) and a heterogeneous group of non-autoimmune arthropathies (controls) with respect to type 1/type 2 balance. Methods. Thirty-five JRA (average 9.1 years' disease duration) and 13 control synovial tissues were studied. As a measure of the type 1/type 2 cytokine balance in a subset of the IRA and control tissues, interferon-gamma (IFN-gamma) and interleukin 4 (IL-4) mRNA levels were measured by competitive fragment reverse transcription-polymerase chain reaction. To quantitate additional cytokines relevant to this balance, multiprobe ribonuclease protection assays were employed measuring IL-5, IL-10, IL-13, IL-15, IL-18, and IL-12 (p35 and p40 subunits). Immunohistochemistry was performed on JRA tissues using antibodies specific for IL-15 and IL-18. Results. A higher IFN-gamma:IL-4 ratio (p = 0.034) was found in JRA tissues compared to controls. JRA tissues also displayed higher mRNA levels of IL-12p35 (p = 0.021), IL- 15 (p = 0.002), and IL-18 (p = 0.017), but not IL-4 and IL-10. IFN-gamma expression in JRA, but not controls, correlated strongly with IL-12P35 (r = 0,63) and IL-12p40 (r = 0.73) levels. A subset of IL-15+ and IL-18+ cells was detected in IRA synovial tissues, largely within perivascular aggregates. Conclusion. JRA synovial tissue cytokine expression patterns indicate a type 1 bias, even in the later stages of disease. The strong correlation between IFN-gamma and IL- 12 in JRA suggests a prominent role for IL- 12 in promoting the type 1 bias, while IL- 15 and IL- 18 may also indirectly increase IFN-gamma expression and further bias the immune response.
引用
收藏
页码:369 / 378
页数:10
相关论文
共 62 条
  • [1] Interleukin-15 promotes angiogenesis in vivo
    Angiolillo, AL
    Kanegane, H
    Sgadari, C
    Reaman, GH
    Tosato, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (01) : 231 - 237
  • [2] Avice MN, 1998, J IMMUNOL, V161, P3408
  • [3] Barbulescu K, 1998, J IMMUNOL, V160, P3642
  • [4] Bradley LM, 1999, J IMMUNOL, V162, P2511
  • [5] Interleukin-15 protects from lethal apoptosis in vivo
    BulfonePaus, S
    Ungureanu, D
    Pohl, T
    Lindner, G
    Paus, R
    Ruckert, R
    Krause, H
    Kunzendorf, U
    [J]. NATURE MEDICINE, 1997, 3 (10) : 1124 - 1128
  • [6] Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro
    Carson, WE
    Ross, ME
    Baiocchi, RA
    Marien, MJ
    Boiani, N
    Grabstein, K
    Caligiuri, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) : 2578 - 2582
  • [7] IL-12 in autoimmunity
    Caspi, NR
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 88 (01): : 4 - 13
  • [8] A STUDY OF CLASSIFICATION CRITERIA FOR A DIAGNOSIS OF JUVENILE RHEUMATOID-ARTHRITIS
    CASSIDY, JT
    LEVINSON, JE
    BASS, JC
    BAUM, J
    BREWER, EJ
    FINK, CW
    HANSON, V
    JACOBS, JC
    MASI, AT
    SCHALLER, JG
    FRIES, JF
    MCSHANE, D
    YOUNG, D
    [J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (02): : 274 - 281
  • [9] Cohen SBA, 1997, J IMMUNOL, V158, P5596
  • [10] INTERLEUKIN-10 (IL-10) INHIBITS HUMAN LYMPHOCYTE INTERFERON GAMMA-PRODUCTION BY SUPPRESSING NATURAL-KILLER-CELL STIMULATORY FACTOR/IL-12 SYNTHESIS IN ACCESSORY CELLS
    DANDREA, A
    ASTEAMEZAGA, M
    VALIANTE, NM
    MA, XJ
    KUBIN, M
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) : 1041 - 1048